Senior Director, Drug Safety and Pharmacovigilance

Senior Director, Drug Safety And Pharmacovigilance

When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a "moneyball for biotech" approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma.

Calcilytix Therapeutics, an affiliate within BridgeBio Pharma, is developing encaleret, a negative allosteric modulator of the calcium-sensing receptor (CaSR) for the treatment of Autosomal Dominant Hypocalcemia Type 1 (ADH1), a genetic cause of hypoparathyroidism. Encaleret is currently being evaluated in a Phase 3 clinical study and has received Orphan Drug Designation from the US FDA, EMA, and PMDA as well as Fast Track Designation from the US FDA. Results from the Phase 2b clinical study of encaleret in patients in ADH1 were published in the New England Journal of Medicine.

Oversight and understanding of all aspects of the assigned product's safety profile from clinical development to post-approval safety surveillance, including management of CROs and other partners that provide clinical and safety data

Facilitate Safety Management Committee for designated product(s), responsible for identifying any emerging safety trends, defining the safety profile, and recommending safety actions based upon cumulative safety data

In collaboration with the regulatory and clinical development team, establish the safety strategy for marketing authorization applications, including the preparation of CTD documents, engagement with regulatory authorities, and authoring responses to inquiries

Support the clinical development team in the review of key documents, including protocol and ICFs

Manage the drug safety contract service organizations (CROs) for clinical programs to ensure compliance with expedited reporting, manage on-time and scientifically sound DSUR preparation, and ensure the drug safety functions of the CROs meet corporate goals and key performance indicators

Assist in the medical review of adverse event reports; manage preparation and submission of drug safety expedited reporting in compliance with regulations, when necessary

Develop and prepare assessments of safety data, safety signals, and benefit / risk for internal senior management as well as external partner or regulatory authorities

Assist in the authoring of aggregate reports

This a U.S-based remote role that will generally require three visits per year, or as needed visits to our San Francisco Office.

Bachelor's degree in a health care discipline or equivalent is required, and an advanced degree is preferred

Requires at least ten years of drug safety and pharmacovigilance experience with at least 5 years experience in Clinical Development Safety

Extensive experience with all aspects of safety signal evaluation, including review and analysis of data, collaboration with cross-functional team members and senior management, authoring of required regulatory correspondence, and safety label updates

Experience in both clinical development and post-marketing safety

Experience with Regulatory submissions for NDAs, EU MAAs, and other countries' Regulatory reviews is highly preferred

Experience in drug safety audits and agency inspections

Intimate knowledge of GCP and strong working knowledge of FDA, Good Clinical Practices, and ICH regulations and guidelines

Proven ability to collaborate successfully with clinical trial teams, including data management, clinical sciences, medical monitors, clinical operations, biostats, regulatory, medical writing, and QA

Experience in managing all clinical safety aspects of product quality defect investigations and assessments

Familiar with clinical trial safety database use and CIOMS II and DSUR reporting generation (Argus, ArisG, or VeevaSafety) and Microsoft Office Suite required (Word, Excel, PowerPoint, Project, Outlook)

We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.

Market leading compensation

401K with 100% employer match on first 3% & 50% on the next 2%

Employee stock purchase program

Pre-tax commuter benefits

Referral program with $2,500 award for hired referrals

Comprehensive health care with 100% premiums covered - no cost to you and dependents

Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions)

Hybrid work model - employees have the autonomy in where and how they do their work

Unlimited flexible paid time off - take the time that you need

Paid parental leave - 4 months for birthing parents & 2 months for non-birthing parents

Flex spending accounts & company-provided group term life & disability

Subsidized lunch via Forkable on days worked from our office

People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility

We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching

We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities

Salary $255,000 - $340,000 USD